Request A Call Back
What is Regonix 40mg?
Regorafenib 40mg contains the active ingredient of Regorafenib 40mg, which is an antineoplastic, tyinine kinase inhibitor. Regonix 40mg is a product of Beacon pharmaceutical used for colorectal cancer and liver cancer treatment.
Basic information of the drug Regonix 40mg
- Active ingredient: Regorafenib
- Class: Anticancer drug. Tyinine kinase inhibitors.
- Dosage form: Tablets.
- Packaging: Box of 28 tablets.
- Origin: Beacon.
- Regorafenib 40mg
Pharmacological properties and mechanism of action
- Regorafenib is indicated for treating patients with metastatic colorectal cancer (CRC) who have been previously treated with or are not considered candidates for, a chemotherapy-derived regimen. fluoropyrimidine, anti-VEGF therapy, and an anti-EGFR therapy if the patient has wild-type KRAS.
- Stivarga 40mg
- Erbitux 5mg/ml
- Oxitan 50mg/25ml
- Irinotesin 40mg